Qpharma SRL
The score of Qpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity -96 % Total assets +53 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Qpharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 20 Aug 2025
- Year ended 31 Dec 2023filed on 05 Aug 2024
Qpharma's financial analysis
- Solvency1.4%sector median: 50.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Qpharma
Qpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0799.745.895
- VAT number
- BE0799745895
- Peppol
- Registered · 0208:0799745895 · as of 02 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Mar 2023
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Qpharma (SRL) has been based in Uccle since 2023, active in: business and other management consultancy activities. For 2025, it reports a net profit of 53,114 € and equity of 2,500 €; its revenue is not published. Its solvency stands at 1.4%, below the median of its sector (50.7%).
Companies similar to Qpharma
Companies in the same business, of comparable size and area, outside its group.
- Sjans Business and other management consultancy activities Bornem · balance sheet 184,977 €
- Vajebo Business and other management consultancy activities Pepingen · balance sheet 184,229 €
- Colpeo Consulting Business and other management consultancy activities Rixensart · balance sheet 184,114 €
- DHP Consulting Business and other management consultancy activities Brasschaat · balance sheet 185,364 €
- Nero pro consulting Business and other management consultancy activities Bilzen-Hoeselt · balance sheet 183,595 €
- Dasko Business and other management consultancy activities Geraardsbergen · balance sheet 185,752 €
- Majurome Business and other management consultancy activities Ichtegem · balance sheet 186,033 €
- Lunars Business and other management consultancy activities Deinze · balance sheet 186,044 €
Frequently asked questions about Qpharma
What is the revenue of Qpharma?
Qpharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Qpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0799745895 for Qpharma, if the company is VAT-registered. Its company number (CBE) is 0799.745.895.
Where is the registered office of Qpharma?
According to the CBE register, the registered office of Qpharma is in 1180 Uccle.
What is the equity of Qpharma?
At the close of the 2025 financial year, the equity of Qpharma amounts to 2,500 €, a solvency of 1.4% of total assets.
Who manages Qpharma?
The register lists 1 active mandates at Qpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Qpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →